Fidelity Investments’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,389,660
| Closed | -$10.5M | – | 5760 |
|
|
2022
Q1 | $10.5M | Buy |
6,389,660
+508
| +0% | +$838 | ﹤0.01% | 2098 |
|
|
2021
Q4 | $15.3M | Buy |
6,389,152
+2,523
| +0% | +$6.03K | ﹤0.01% | 1946 |
|
|
2021
Q3 | $34.9M | Buy |
6,386,629
+8,832
| +0.1% | +$48.2K | ﹤0.01% | 1579 |
|
|
2021
Q2 | $47.5M | Buy |
6,377,797
+7,779
| +0.1% | +$57.9K | ﹤0.01% | 1461 |
|
|
2021
Q1 | $51.6M | Buy |
6,370,018
+2,677,459
| +73% | +$21.7M | ﹤0.01% | 1383 |
|
|
2020
Q4 | $33.6M | Buy |
3,692,559
+541,300
| +17% | +$4.93M | ﹤0.01% | 1484 |
|
|
2020
Q3 | $34.9M | Buy |
3,151,259
+436,537
| +16% | +$4.83M | ﹤0.01% | 1333 |
|
|
2020
Q2 | $20.2M | Buy |
2,714,722
+438,715
| +19% | +$3.26M | ﹤0.01% | 1545 |
|
|
2020
Q1 | $14M | Buy |
2,276,007
+189,100
| +9% | +$1.16M | ﹤0.01% | 1557 |
|
|
2019
Q4 | $10.5M | Buy |
2,086,907
+121,283
| +6% | +$609K | ﹤0.01% | 1829 |
|
|
2019
Q3 | $14.8M | Buy |
1,965,624
+40,617
| +2% | +$306K | ﹤0.01% | 1688 |
|
|
2019
Q2 | $21.9M | Buy |
1,925,007
+115,924
| +6% | +$1.32M | ﹤0.01% | 1587 |
|
|
2019
Q1 | $25.1M | Buy |
+1,809,083
| New | +$25.1M | ﹤0.01% | 1493 |
|